OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+23.8%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$239M
AUM Growth
+$239M
(+19%)
Cap. Flow
+$5.52M
Cap. Flow
% of AUM
2.31%
Top 10 Holdings %
Top 10 Hldgs %
60.96%
Holding
53
New
9
Increased
16
Reduced
7
Closed
12
Top Buys
| 1 |
CORI
Corium International, Inc.
CORI
|
$4.13M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$3.04M |
| 3 |
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
|
$2.95M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$2.87M |
| 5 |
Ardelyx
ARDX
|
$2.79M |
Top Sells
| 1 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$7.08M |
| 2 |
Ocular Therapeutix
OCUL
|
$5.1M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$3.2M |
| 4 |
GNMX
Aevi Genomic Medicine, Inc.
GNMX
|
$1.99M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$1.96M |
Sector Composition
| 1 | Healthcare | 91.54% |